Coppell Advisory Solutions’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
Other funds holding ADPT
Coppell Advisory Solutions's ADPT Position: Q3 2026 in Review
Coppell Advisory Solutions opened a new position in Adaptive Biotechnologies (ADPT) in Q3 2026: 15,537 shares worth $447K. The stake represents 0.05% of the portfolio and ranks #224 among its holdings.
334 funds tracked by Wall St. Rank hold ADPT as of Q3 2026.
- Coppell Advisory Solutions held 15,537 shares of Adaptive Biotechnologies worth $447K as of Q3 2026.
- Adaptive Biotechnologies was a new Coppell Advisory Solutions position in Q3 2026.
- Adaptive Biotechnologies made up 0.05% of Coppell Advisory Solutions's portfolio in Q3 2026, its #224 holding.
- 334 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q3 2026.
Based on Coppell Advisory Solutions's 13F filing for Q3 2026, filed 16 Nov 2026.